Chimeric Therapeutics Ltd

NEW
ASX:CHM (Australia)   Ordinary Shares
A$ 0.013 -0.0020 (-13.33%) Aug 25
At Loss
Market Cap:
A$ 920.00K ($ 658.00K)
Enterprise V:
A$ 1.46M ($ 1.04M)
Volume:
2.47M
Avg Vol (2M):
702.36K
Trade In:
Volume:
2.47M
At Loss

Chimeric Therapeutics Ltd (ASX:CHM) Dividend

Chimeric Therapeutics Ltd (ASX:CHM) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -65.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:CHM Dividend

Does Chimeric Therapeutics Ltd (ASX:CHM) pay a dividend?

Chimeric Therapeutics Ltd (ASX:CHM) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Chimeric Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Chimeric Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -65.3% over the past 3 years.

What are dividend-paying alternatives to Chimeric Therapeutics Ltd?

For dividend-paying alternatives in Chimeric Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.